World

Mauritius PM concedes defeat in parliamentary election

Nov 12, 2024

Port Louis [Mauritius], November 12: Pravind Jugnauth, the incumbent prime minister of Mauritius, has conceded defeat in the parliamentary election, saying his political alliance is headed for a major loss.
"L'Alliance Lepep is heading towards a huge defeat. I have tried to do what I can for the country and the population. The population has decided to choose another team. I wish good luck to the country," Jugnauth, serving as prime minister since 2017, told reporters on Monday.
Final results have yet to be officially released, but opposition leader Navin Ramgoolam looks set to take over as prime minister for the third time at the head of his Alliance of Change coalition.
Voters went to the polls on Sunday to elect legislators for the 62 seats in parliament for the next five years, from a list of 68 parties and five political alliances. The party or coalition to receive more than half the seats in parliament will also win the prime minister's post.
Only last month, Jugnauth, 62, was celebrating a historic deal with the United Kingdom to regain sovereignty over the Chagos Islands following a long-running dispute. But the campaign was overshadowed by an explosive wire-tapping scandal, when secretly recorded phone calls of politicians, diplomats and journalists were leaked online. During a heated campaign, both camps promised voters they would take measures to improve the lives of Mauritians who face cost-of-living difficulties despite strong economic growth.
Source: Qatar Tribune

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025